July 27, 2021 | From the Trenches

Scaling Thoughtfully: The Art Of Sharing Responsibilities Across A Growing Team

The opportunity for each member of a NewCo to take on multiple responsibilities selects early for people ready to help a startup get its footing. We were no exception at Spero, when we started off with a $400k seed investment a little more than 6 years ago. Funds were tight to hire a controller and we were weeks away from a go/no go data point, so I put on my green visor and volunteered (fortunately briefly!) to do the company’s accounting. Thankfully, the science advanced, we raised funds, and I was thrilled to give that responsibility up to a great team. Sometimes, though, the choice to give up a responsibility is not that easy.

By Ankit Mahadevia, CEO and Founder of Spero Therapeutics, as part of the From The Trenches feature of LifeSciVC.

July 16, 2021 | In the News

Generation Bio snaps up Boston area plant as it rolls out a manufacturing process it thinks will be a game changer

Generation Bio is looking to move the field of gene therapy into the future, and thinks it has a manufacturing process in place that will allow enough scale for broad disease indications. Now, all it needs is a plant to put those large-scale ambitions into action.

July 13, 2021 | From the Trenches

Immuno-Oncology: The Comeback Kid

Now 10 years into the golden era of immuno-oncology (I-O) following the first FDA approval of ipilimumab (anti-CTLA4) in 2011 and the seminal initial efficacy disclosure on nivolumab (anti-PD1) in 2012 (Topalian et al NEJM), we can reflect on how I-O has literally changed the lives of tens of thousands of cancer patients and their families.

By Tim Reilly & Jonathan Montagu, CDO and CEO of HotSpot Therapeutics, as part of the From The Trenches feature of LifeSciVC

July 12, 2021 | Press Release

Atlas Venture Welcomes Jodie Morrison as Venture Partner

Atlas Venture, a leading early stage venture capital firm, announced today that Jodie Morrison is joining the firm as a venture partner. Jodie will work with the Atlas team to build transformative new biotech companies.

July 9, 2021 | From the Trenches

SPAC downpour continues

Holy cow, have we seen the rain lately – both downpours outside and a downpour of SPAC activity.

By Sam Truex, Venture Partner at Atlas Venture, as part of the From The Trenches feature of LifeSciVC.